These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8588236)

  • 21. Australian cyclosporin therapeutic monitoring method survey: 1993.
    Morris RG
    Ther Drug Monit; 1994 Dec; 16(6):564-9. PubMed ID: 7878695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of cyclosporin G in the mouse, rat, and dog.
    Mangold JB; Rodriguez LC; Wang YK
    Drug Metab Dispos; 1995 Jun; 23(6):615-21. PubMed ID: 7587942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
    Oellerich M; Armstrong VW; Schütz E; Shaw LM
    Clin Biochem; 1998 Jul; 31(5):309-16. PubMed ID: 9721427
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
    Roos K; Gotthardt D; Giese T; Schnitzler P; Stremmel W; Czock D; Eisenbach C
    Liver Transpl; 2014 Sep; 20(9):1106-17. PubMed ID: 24890314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that cyclosporine G is less deleterious to rat bone in vivo than cyclosporine A.
    Stein B; Takizawa M; Schlosberg M; Movsowitz C; Fallon M; Berlin JA; Epstein S
    Transplantation; 1992 Mar; 53(3):628-32. PubMed ID: 1549857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of cyclosporin A, cyclosporin G, and the novel cyclosporin derivative IMM 125 in isolated glomeruli and cultured rat mesangial cells: a morphometric analysis.
    Potier M; Wolf A; Cambar J
    Nephrol Dial Transplant; 1998 Jun; 13(6):1406-11. PubMed ID: 9641169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoring.
    Morris RG
    Ther Drug Monit; 2000 Apr; 22(2):160-2. PubMed ID: 10774626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients.
    Baraldo M; Pea F; Poz D; Furlanut M
    Pharmacol Res; 2001 Jun; 43(6):547-51. PubMed ID: 11419964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and metabolism of cyclosporin G in humans.
    Mangold JB; Schran HF; Tse FL
    Drug Metab Dispos; 1994; 22(6):873-9. PubMed ID: 7895604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality assurance programs for immunosuppressive drugs: cyclosporine and beyond.
    Holt DW; Marwaha G; Jones K; Johnston A
    Ther Drug Monit; 1993 Dec; 15(6):472-7. PubMed ID: 8122279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic drug monitoring of cyclosporine microemulsion in patients with corticosteroid-resistant systemic lupus erythematosus.
    Wada Y; Kotani T; Takeuchi T; Wakura R; Wakura D; Makino S; Hanafusa T
    Mod Rheumatol; 2015 Sep; 25(5):708-13. PubMed ID: 25835315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine A: clinical experience and therapeutic drug monitoring.
    Lindholm A
    Ther Drug Monit; 1995 Dec; 17(6):631-7. PubMed ID: 8588233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
    Yatscoff RW; LeGatt DF; Kneteman NM
    Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of cyclosporine on the development of immunosuppressive therapy--pediatric transplantation using cyclosporine.
    Hoyer PF; Vester U
    Transplant Proc; 2004 Mar; 36(2 Suppl):197S-202S. PubMed ID: 15041336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of less chronic nephrotoxicity by cyclosporine G than cyclosporine A in a low-salt rat model.
    Burdmann EA; Rosen S; Lindsley J; Elzinga L; Andoh T; Bennett WM
    Transplantation; 1993 May; 55(5):963-6. PubMed ID: 8497907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.
    Dick AD; Azim M; Forrester JV
    Br J Ophthalmol; 1997 Dec; 81(12):1107-12. PubMed ID: 9497474
    [No Abstract]   [Full Text] [Related]  

  • 37. Whole-blood cyclosporin G in renal transplant recipients determined by two immunoassays and liquid chromatography.
    McBride JH; Kim SS; Danovitch GM; Rodgerson DO; Reyes AF; Ota MK
    Clin Chem; 1993 Jul; 39(7):1415-9. PubMed ID: 8330399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin pharmacokinetics in paediatric transplant recipients.
    Cooney GF; Habucky K; Hoppu K
    Clin Pharmacokinet; 1997 Jun; 32(6):481-95. PubMed ID: 9195117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Twenty-five years of cyclosporin use in transplantation medicine].
    Hesselink DA; van Hagen PM; Balk AH; van Hal PT; Weimar W; van Gelder T
    Ned Tijdschr Geneeskd; 2003 May; 147(20):959-64. PubMed ID: 12784529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytic aspects of cyclosporine monitoring, on behalf of the IFCC/IATDMCT Joint Working Group.
    Morris RG; Holt DW; Armstrong VW; Griesmacher A; Napoli KL; Shaw LM;
    Ther Drug Monit; 2004 Apr; 26(2):227-30. PubMed ID: 15228170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.